Cause-specific death assessment of patients with stage I small-cell lung cancer: a competing risk analysis

被引：8
|
作者：
Liu, Jiaqing [1 ,2 ,3 ,4 ]
Zhou, Huaqiang [1 ,2 ,3 ,4 ]
Zhang, Yaxiong [1 ,2 ,3 ]
Fang, Wenfeng [1 ,2 ,3 ]
Yang, Yunpeng [1 ,2 ,3 ]
Hong, Shaodong [1 ,2 ,3 ]
Chen, Gang [1 ,2 ,3 ]
Zhao, Shen [1 ,2 ,3 ]
Chen, Xi [1 ,2 ,3 ]
Zhang, Zhonghan [1 ,2 ,3 ]
Xian, Wei [4 ]
Shen, Jiayi [4 ]
Huang, Yan [1 ,2 ,3 ]
Zhao, Hongyun [1 ,2 ,3 ]
Zhang, Li [1 ,2 ,3 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China
[2] State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[3] Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China
来源：
FUTURE ONCOLOGY | 2019年 / 15卷 / 21期
基金：
国家重点研发计划;
关键词：
cancer-specific death; competing risk nomogram; SCLC; SEER; SURVIVAL; SURGERY; COMORBIDITY; NOMOGRAM; OUTCOMES; LIMITATIONS; MORTALITY; PREDICT; IMPACT; NEED;
D O I：
10.2217/fon-2018-0888
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Aim: Stage I small-cell lung cancer (SCLC) is a potentially curable disease that needs timely and multidisciplinary management. The aim of this study was to evaluate the probability of cause-specific mortality for patients with stage I SCLC. Material & methods: We identified patients in the SEER database and constructed a proportional subdistribution hazard model to evaluate cancer-specific mortality. A nomogram was built based on Fine and Gray competing risk regression model. Results:A total of864 stage I SCLC patients were identified. The 5-year cumulative incidence of SCLC-specific mortality was 56.2%, while that for other causes of death was 17.3%. The c-index for the prognostic prediction model was 0.66. Besides, the nomogram was well calibrated. Conclusion: Our nomogram might serve as a reference for clinicians when evaluating the prognosis of stage I SCLC.
引用
收藏
页码：2479 / 2488
页数：10
相关论文
共 50 条
  • [31] The diagnosis of limited stage small-cell lung cancer
    Sas-Korczynska, Beata
    Wojcik, Ewa
    Luczynska, Elzbieta
    Kulpa, Jan
    Korzeniowski, Stanislaw
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2008, 12 (01): : 1 - 5
  • [32] The role of surgery in stage I small-cell lung cancer: A national VA database analysis.
    Azar, Ibrahim
    Austin, Adam
    Kim, Seongho
    Jang, Hyejeong
    Chopra, Amit
    Mehdi, Syed Arzoo
    Mamdani, Hirva
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [33] Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis
    Zhang, Xu
    Xu, Fengshuo
    Bin, Yadi
    Liu, Tianjie
    Li, Zhichao
    Guo, Dan
    Li, Yarui
    Huang, Qiao
    Lyu, Jun
    He, Shuixiang
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [34] Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis
    Xu Zhang
    Fengshuo Xu
    Yadi Bin
    Tianjie Liu
    Zhichao Li
    Dan Guo
    Yarui Li
    Qiao Huang
    Jun Lyu
    Shuixiang He
    BMC Gastroenterology, 22
  • [35] Competing Risk of Death in Elderly Patients with Newly Diagnosed Stage I Breast Cancer
    Wasif, Nabil
    Neville, Matthew
    Gray, Richard
    Cronin, Patricia
    Pockaj, Barbara A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (01) : 30 - +
  • [36] Interstitial Lung Abnormalities are a Risk Factor for Radiation Pneumonitis in Patients with Limited-Stage Small-Cell Lung Cancer
    Li, F.
    Liang, S.
    Wu, H.
    Cai, Y.
    Xu, Y.
    Chen, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S797 - S798
  • [37] New strategies for patients with limited-stage small-cell lung cancer
    Schneiders, Famke L.
    Senan, Suresh
    LANCET RESPIRATORY MEDICINE, 2024, 12 (10): : 748 - 750
  • [38] Risk factors for non-cancer death after surgery in patients with stage I non-small-cell lung cancer
    Kanzaki, Ryu
    Nagoya, Akihiro
    Kanou, Takashi
    Ose, Naoko
    Funaki, Soichiro
    Minami, Masato
    Okamoto, Yuna
    Tabuchi, Hiroto
    Hoshino, Tomoko
    Tajima, Tetsuya
    Fujii, Makoto
    Ohno, Yuko
    Shintani, Yasushi
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2021, 59 (03) : 633 - 640
  • [39] Stage I and II Small-Cell Lung Cancer-New Challenge for Surgery
    Doerr, Fabian
    Stange, Sebastian
    Michel, Maximilian
    Schlachtenberger, Georg
    Menghesha, Hruy
    Wahlers, Thorsten
    Hekmat, Khosro
    Heldwein, Matthias B.
    LUNG, 2022, 200 (04) : 505 - 512
  • [40] SURGICAL EXCISION IN STAGE-I-II SMALL-CELL LUNG-CANCER
    SIVARAJAN, KM
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) : 1704 - 1704
12345